|
|
| (29 intermediate revisions by 2 users not shown) |
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[COVID-19 Pulmonary Complications]] |
| To go to the COVID-19 project topics list, click '''[[COVID-19 Project Topics|here]]'''.
| |
| | |
| {{CMG}} {{AE}} {{S.M.}}
| |
| ==Overview==
| |
| [[Covid19|Covid-19]] [[infection]] is [[Association (statistics)|associated]] with [[pulmonary]] [[complications]] such as [[acute respiratory distress syndrome]], [[pneumonia]], [[pulmonary embolism]], [[hypoxemia]], [[superinfection]], [[respiratory failure]], and increased [[mortality]] in [[patients]] with an [[Underlying representation|underlying]] [[pulmonary disease]] such as [[chronic obstructive pulmonary disease]] ([[Chronic obstructive pulmonary disease|COPD]]).
| |
| | |
| ==Complications==
| |
| | |
| ===Acute respiratory distress syndrome===
| |
| *
| |
| | |
| ===Pneumonia===
| |
| | |
| ===Pulmonary embolism===
| |
| | |
| ===Hypoxemia===
| |
| | |
| ===Superinfection===
| |
| | |
| ===Respiratory failure===
| |
| | |
| ===Increased mortality in COPD patients===
| |
| *According to a [[Study design|study]] [[Conduct|conducted]] in China, having an [[Underlying representation|underlying]] [[comorbidity]] such as [[chronic obstructive pulmonary disease]] ([[Chronic obstructive pulmonary disease|COPD]]) conferred a [[mortality]] [[hazard ratio]] of 2.681, even after adjusting for [[smoking]] status.<ref name="pmid32145829">{{cite journal| author=Ñamendys-Silva SA| title=Respiratory support for patients with COVID-19 infection. | journal=Lancet Respir Med | year= 2020 | volume= 8 | issue= 4 | pages= e18 | pmid=32145829 | doi=10.1016/S2213-2600(20)30110-7 | pmc=7129706 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32145829 }} </ref>
| |
| | |
| ==References==
| |
| <references />
| |